LobbyingThe Mount Sinai Hospital lobbying by quarter
The Mount Sinai Hospital's latest lobbying report covers Q2 2026, at $130K. The four quarters Q4 2025–Q3 2026 total $630K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
The Mount Sinai Hospital
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $630K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 1 |
| Q1 2023 | $360K | 1 |
| Q2 2023 | $60K | 1 |
| Q3 2023 | $30K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $270K | 1 |
| Q2 2024 | $40K | 1 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $230K | 1 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $160K | 1 |
| Q4 2025 | $160K | 1 |
| Q1 2026 | $340K | 1 |
| Q2 2026 | $130K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$951.7K · 15 reports
- Medicare and Medicaid$951.7K · 15 reports
- Budget and appropriations$53.3K · 1 reports
- Medical research and clinical labs$20K · 1 reports
- Homeland security$13.3K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE14 reports
- Natl Security Council (NSC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseThe Mount Sinai Hospital | $2M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $130K |
| 04/20for Q1 | In-house | $340K |
| 01/20for Q4 2025 | In-house | $160K |
| 25/10/20for Q3 2025 | In-house | $160K |
| 25/07/21for Q2 2025 | In-house | $60K |
| 25/04/21for Q1 2025 | In-house | $230K |
| 25/01/21for Q4 2024 | In-house | $30K |
| 24/10/21for Q3 2024 | In-house | $40K |
| 24/07/22for Q2 2024 | In-house | $40K |
| 24/04/22for Q1 2024 | In-house | $270K |
| 24/01/22for Q4 2023 | In-house | $30K |
| 23/10/20for Q3 2023 | In-house | $30K |
| 23/07/20for Q2 2023 | In-house | $60K |
| 23/04/20for Q1 2023 | In-house | $360K |
| 23/01/20for Q4 2022 | In-house | $50K |